LogoCrystal's MCW Coder Hub

H30.003

18 min read

🧬 ICD-10 CM H30.003 — Unspecified Focal Chorioretinal Inflammation, Bilateral

Billable Code Confirmed

ICD-10 CM H30.003 is a valid, billable 6-character ICD-10-CM code for FY2026. All six characters are present: H30 (category) + .0 (focal chorioretinal inflammation) + 0 (unspecified focal location) + 3 (bilateral). No 7th character is required.

Non-Billable Parent Codes — Never Submit These

  • ❌ H30.00 — 5-character header — missing laterality character
  • ❌ H30.0 — 4-character header — missing location specification and laterality

Always submit H30.003 (all 6 characters) when bilateral focal chorioretinal inflammation with an unspecified focal location is documented.

Clinical Context: "Unspecified" Location vs. Specific Location

ICD-10 CM H30.003 indicates focal (single discrete lesion or lesions) bilateral chorioretinal inflammation, but the 00 signifies the anatomic location of the focus — juxtapapillary, posterior pole, peripheral, or macular/ paramacular — is unspecified. If the operative report or exam specifies the location of the lesion(s), a more specific code is strongly preferred over H30.003.

Code Classification

ICD-10-CM Diagnosis Code — Fields for wRVU, assistant payable, and global period are not applicable. For associated inpatient procedure coding, see the ICD-10-PCS Crosswalk section below.

🔍 Code Description

ICD-10 CM H30.003 classifies bilateral unspecified focal chorioretinal inflammation — a discrete, localized inflammatory process involving the choroid and/or retina in both eyes, where the specific anatomic location of the lesion(s) within the fundus has not been further characterized in the medical record.

The term focal distinguishes this condition from disseminated chorioretinal inflammation (H30.103 and related codes), which involves multiple scattered or widespread foci throughout the posterior segment. Focal implies a single discrete lesion or a tightly grouped cluster of lesions — not a diffuse, multifocal process. The qualifier “unspecified” within H30.00x reflects that while the physician has documented focal inflammation, the precise anatomic site has not been specified as juxtapapillary, posterior pole, peripheral, or macular/paramacular.

The bilateral character (6th character = 3) indicates both eyes are involved. Bilateral focal chorioretinal inflammation raises the index of suspicion for a systemic or infectious etiology — conditions such as ocular toxoplasmosis, sarcoidosis, syphilis, and viral infections commonly produce bilateral posterior segment lesions, even when one eye is more severely affected.

🌳 Code Tree / Hierarchy

H30 Chorioretinal Inflammation  
│  
├── H30.0 Focal chorioretinal inflammation ❌ Non-billable  
│ │  
│ ├── H30.00 Unspecified focal chorioretinal inflammation ❌ Non-billable  
│ │ ├── H30.001 Right eye ✅ Billable  
│ │ ├── H30.002 Left eye ✅ Billable  
│ │ ├── H30.003 BILATERAL ◀ THIS CODE ✅ Billable  
│ │ └── H30.009 Unspecified eye ⚠️ Avoid — query laterality  
│ │  
│ ├── H30.01 Focal, juxtapapillary (Jensen's chorioretinitis)  
│ │ ├── H30.011 Right eye ✅ Billable  
│ │ ├── H30.012 Left eye ✅ Billable  
│ │ ├── H30.013 Bilateral ✅ Billable  
│ │ └── H30.019 Unspecified eye ⚠️ Avoid  
│ │  
│ ├── H30.02 Focal, posterior pole  
│ │ ├── H30.021 Right eye ✅ Billable  
│ │ ├── H30.022 Left eye ✅ Billable  
│ │ ├── H30.023 Bilateral ✅ Billable  
│ │ └── H30.029 Unspecified eye ⚠️ Avoid  
│ │  
│ ├── H30.03 Focal, peripheral  
│ │ ├── H30.031 Right eye ✅ Billable  
│ │ ├── H30.032 Left eye ✅ Billable  
│ │ ├── H30.033 Bilateral ✅ Billable  
│ │ └── H30.039 Unspecified eye ⚠️ Avoid  
│ │  
│ └── H30.04 Focal, macular or paramacular  
│ ├── H30.041 Right eye ✅ Billable  
│ ├── H30.042 Left eye ✅ Billable  
│ ├── H30.043 Bilateral ✅ Billable  
│ └── H30.049 Unspecified eye ⚠️ Avoid  
│  
├── H30.1 Disseminated chorioretinal inflammation ← See [[H30.103]]  
├── H30.2 Posterior cyclitis (pars planitis)  
├── H30.8 Other chorioretinal inflammations  
└── H30.9 Unspecified chorioretinal inflammation

Upgrade Specificity When Possible

H30.003 should only be assigned when the anatomic location of the focal lesion is genuinely unspecified or undocumented. If the physician documents or the fundus exam clearly places the lesion — juxtapapillary → H30.013; posterior pole → H30.023; peripheral → H30.033; macular or paramacular → H30.043. A CDI query is appropriate if the record contains enough clinical detail to support a more specific location code.

✅ Includes

The following clinical terms and scenarios map to H30.003 when bilateral and focal location is unspecified:

  • Bilateral focal chorioretinitis NOS
  • Bilateral focal choroiditis NOS
  • Bilateral focal retinitis NOS
  • Bilateral focal retinochoroiditis NOS
  • Bilateral single discrete chorioretinal inflammatory lesion, location not specified

The terms chorioretinitis (choroid → retina involvement) and retinochoroiditis (retina → choroid involvement) are used interchangeably in clinical documentation and map identically to this subcategory.

❌ Excludes

Excludes 1 — Cannot Be Coded Simultaneously with H30.003

CodeDescriptionNote
H35.02-Exudative retinopathy (Coats disease)Mutually exclusive — Coats disease presents with retinal telangiectasia and exudation that can mimic inflammatory chorioretinal disease; if diagnosis is Coats, assign H35.023 (bilateral), not H30.003

Excludes 1 Violation Risk

H35.02- (exudative retinopathy / Coats disease) carries an Excludes 1 instruction at the H30.1 subcategory level that applies across H30.0x as well. These conditions are mutually exclusive and cannot be assigned simultaneously. If the diagnosis is confirmed as Coats disease, assign H35.023 (bilateral), not H30.003.

Excludes 2 — May Be Coded in Addition if Separately Present

CodeDescriptionNote
H44.1-Sympathetic uveitisExcludes 2 at H30 category level — may be coded additionally if separately documented and clinically distinct from the focal chorioretinal inflammation

Excludes 2 — Not Mutually Exclusive

H44.1- (sympathetic uveitis, e.g., H44.133 bilateral) is an Excludes 2 entry at the H30 category level. Both codes may be assigned if sympathetic uveitis is separately and distinctly documented alongside focal chorioretinal inflammation. Do not routinely add H44.1- without explicit physician documentation.

📋 Clinical Overview

Focal vs. Disseminated — The Critical Distinction

The H30.0x vs. H30.1x determination is the single most important coding decision in the H30 category. The distinction must come from physician documentation — coders should not infer it from imaging descriptions alone.

FeatureFocal — H30.0xDisseminated — H30.1x
Lesion patternSingle discrete lesion or tightly grouped clusterMultiple scattered or coalescent foci
Fundus extentConfined to one anatomic areaWidespread or multifocal throughout fundus
Typical etiologyToxoplasmosis (classic), focal bacterial/viralHematogenous seeding, immune-mediated, systemic
Common descriptors”Single focus,” “discrete lesion,” “one active site""Multiple lesions,” “scattered,” “disseminated”
ICD-10-CM code familyH30.0x — this code familyH30.1x — H30.103 bilateral

CDI Query Trigger — Focal vs. Disseminated

If the physician documents only “chorioretinitis” or “chorioretinal inflammation” without specifying focal vs. disseminated, a CDI query is warranted. The distinction between H30.0x (focal) and H30.1x (disseminated) requires physician documentation and cannot be inferred by the coder. Both are billable; neither is the default.

Pathophysiology

Focal chorioretinal inflammation represents a localized inflammatory reaction within the choroid and/or retina, most commonly resulting from direct microbial seeding, reactivation of a latent organism within a prior scar, or a localized immune-mediated response. The choroid’s rich blood supply makes it particularly susceptible to hematogenous seeding — organisms reaching the choriocapillaris can establish discrete infectious foci that then spread into the overlying retina, producing the classic white-yellow lesion with surrounding edema and associated vitritis.

In bilateral focal disease specifically, the most common etiology is reactivated ocular toxoplasmosis — the organism establishes latent cysts within the retina after primary infection and can reactivate simultaneously or sequentially in both eyes, though bilateral simultaneous active disease is less common than unilateral reactivation. When bilateral focal lesions are documented, the infectious and systemic workup is expanded accordingly.

Etiology

CauseICD-10-CM CodeSequencing Note
Toxoplasma gondiiB58.01Most common cause of focal chorioretinitis globally; sequence etiology first when identified
Secondary syphilis (ocular)A51.43Sequence etiology; H30.003 adds bilateral focal pattern specificity
Late syphilitic chorioretinitisA52.71Per tabular guidance; bilateral presentation common in late/tertiary syphilis
Tuberculous chorioretinitisA18.53Sequence etiology first; TB is an important bilateral posterior segment cause
CMV retinitisB25.8In immunocompromised; B20 sequences first in HIV/AIDS admissions
Bartonella (cat scratch disease)A28.1Neuroretinitis and focal chorioretinal lesions
Idiopathic / non-infectiousNo organism codeH30.003 as principal or secondary; immune-mediated workup
Sarcoidosis with ocular involvementD86.83Code sarcoidosis additionally; bilateral focal lesions are a classic sarcoid presentation

Sequencing Principle

When a causative organism or systemic condition is identified and drives the admission, code the underlying etiology first, followed by H30.003 as the manifestation, per ICD-10-CM Official Coding Guidelines Chapter 1 and tabular “code first” conventions. If etiology is unknown, H30.003 sequences as principal without an additional organism code.

Clinical Presentation

Patients with bilateral focal chorioretinal inflammation typically present with one or more of the following:

  • Blurred vision in one or both eyes — severity varies by lesion proximity to the fovea; macular or paramacular lesions cause acute central vision loss while peripheral lesions may be asymptomatic
  • Floaters — vitreous cells or inflammatory debris
  • Photophobia and photopsia (flashes)
  • Scotoma corresponding to the location of the active lesion
  • Fundoscopic findings:
    • Single white-yellow fluffy or creamy lesion in the choroid/retina, with surrounding retinal edema and hazy borders during the active phase
    • Adjacent chorioretinal scar from prior healed episode (classic in toxoplasmosis reactivation — “satellite lesion” adjacent to an old scar)
    • Overlying vitritis — “headlights in fog” appearance
    • RPE disturbance and pigmentation at healing or healed lesion margins

Documentation Requirements

For accurate assignment of H30.003, physician documentation should include:

  1. Laterality — bilateral explicitly documented
  2. Pattern — focal (single discrete lesion) vs. disseminated (multiple scattered foci) — the critical H30.0x vs. H30.1x distinction
  3. Anatomic location — juxtapapillary, posterior pole, peripheral, or macular/paramacular enables sub-subcategory specificity upgrade
  4. Etiology or suspected cause — if identified, drives additional code assignment and sequencing
  5. Active vs. inactive/scarring — active inflammation vs. old chorioretinal scar (Z87.39x or H31.0x for scar) are different clinical and coding scenarios

💰 HCC Risk Adjustment (CMS-HCC v28)

FieldDetail
CMS-HCC Model Versionv28 (2024–2025 Implementation)
HCC Assignment❌ Not Mapped
HCC CategoryN/A
RAF Coefficient0.000
RxHCC AssignmentNot Mapped

H30.003 does not map to an HCC under CMS-HCC v28 and does not contribute to a patient’s Risk Adjustment Factor (RAF) score.

Monitor for RAF-Bearing Comorbidities and Sequelae

While H30.003 itself carries no HCC weight, the conditions that cause or coexist with bilateral focal chorioretinal inflammation frequently do. At every H30.003 encounter, review and ensure complete coding of:

  • HIV disease (B20) — HCC 1 (v28) — very high RAF coefficient
  • Diabetes mellitus with complications — HCC 18/19 series
  • Sarcoidosis (D86.83) — review HCC mapping
  • Vision impairment or blindness (H54.x) — review for HCC mapping if visual loss is documented as a sequela
  • Autoimmune conditions driving the inflammation — review individually

Do not leave risk-adjustable comorbidities undercoded. All conditions meeting UHDDS criteria for “other diagnoses” must be reported.

🏥 MS-DRG Assignment

MDC 02 — Diseases and Disorders of the Eye

DRGTitleEst. Relative Weight*
DRG 124Other Disorders of the Eye with MCC~0.95–1.15
DRG 125Other Disorders of the Eye with CC~0.70–0.90
DRG 126Other Disorders of the Eye without CC/MCC~0.50–0.70

*Approximate. Verify against IPPS FY2026 Final Rule tables.

HIV and Systemic Etiology — Principal Diagnosis May Shift MDC

If the patient is admitted with HIV disease (B20) and the focal chorioretinal inflammation is an HIV-related manifestation, B20 sequences as principal per ICD-10-CM Official Guidelines Section I.C.1.a.2. The encounter then groups to MDC 25 (HIV/AIDS), not MDC 02. Similarly, if admission is driven by disseminated toxoplasmosis (B58.01), sequence the infection as principal — H30.003 becomes the additional diagnosis. Always evaluate reason for admission first.

🔗 Related ICD-10-CM Codes

Laterality Variants of This Code

CodeDescription
H30.001Unspecified focal chorioretinal inflammation, right eye
H30.002Unspecified focal chorioretinal inflammation, left eye
H30.003Unspecified focal chorioretinal inflammation, bilateral ← This Code
H30.009Unspecified focal chorioretinal inflammation, unspecified eye ⚠️ non-billable header — do not use

Upgrade Codes — Bilateral Focal by Anatomic Location

CodeDescription
H30.013Focal chorioretinal inflammation, juxtapapillary (Jensen’s), bilateral
H30.023Focal chorioretinal inflammation, posterior pole, bilateral
H30.033Focal chorioretinal inflammation, peripheral, bilateral
H30.043Focal chorioretinal inflammation, macular or paramacular, bilateral

These Four Codes Are Always Preferred Over H30.003

If the physician documents or can be queried to confirm the anatomic location of the bilateral focal lesion(s), one of the four codes above replaces H30.003. Reserve H30.003 strictly for when location is genuinely undocumented after a query attempt.

Disseminated Variants (Contrast — H30.1x)

CodeDescription
H30.103Unspecified disseminated chorioretinal inflammation, bilateral
H30.113Disseminated, posterior pole, bilateral
H30.123Peripheral disseminated chorioretinal inflammation, bilateral
H30.133Generalized disseminated chorioretinal inflammation, bilateral

Infectious Etiology Codes (Assign in Addition When Documented)

CodeDescription
B58.01Toxoplasma chorioretinitis — most common cause of focal chorioretinitis worldwide
A51.43Secondary syphilitic oculopathy
A52.71Late syphilitic oculopathy (chorioretinitis)
A18.53Tuberculous chorioretinitis
B25.8Other cytomegaloviral diseases (CMV retinitis)
B20HIV disease (sequences as principal in HIV-related admissions)
A28.1Cat-scratch disease (Bartonella) — neuroretinitis/focal chorioretinal lesion

Associated and Differential Diagnosis Codes

CodeDescriptionCoding Relevance
D86.83Sarcoidosis of eyeBilateral focal posterior lesions classic for sarcoid; code additionally when documented
H30.103Unspecified disseminated chorioretinitis, bilateralDistinct entity — multiple scattered foci vs. single discrete; query to differentiate
H44.133Sympathetic uveitis, bilateralExcludes 2 at H30 category — may code additionally if distinctly documented
H35.023Exudative retinopathy (Coats disease), bilateralExcludes 1 — cannot code with H30.003; mutually exclusive
H31.003Unspecified chorioretinal scars, bilateralOld healed lesion — if the lesion is documented as scarred/inactive, H31.0x is more appropriate than H30.003

🛠️ Commonly Associated CPT Codes (Ophthalmology)

Outpatient and Physician Setting Context

The CPT codes below are associated with the diagnostic workup and ongoing management of bilateral focal chorioretinal inflammation in outpatient and physician fee schedule settings. In the inpatient setting, ICD-10-PCS procedure codes govern procedural reporting.

CPT CodeDescriptionClinical Application
92004Ophthalmological exam, comprehensive, new patientInitial workup and bilateral focal chorioretinitis diagnosis
92014Ophthalmological exam, comprehensive, established patientFollow-up for known bilateral focal chorioretinal inflammation
92250Fundus photography with interpretation and reportDocuments baseline bilateral lesion morphology and tracks change over time
92235Fluorescein angiography with interpretation and reportEvaluates vascular leakage, hyperfluorescence, and late staining at active bilateral lesions
92134Scanning computerized ophthalmic diagnostic imaging, posterior segment (OCT)Subretinal fluid detection, retinal thickness mapping, CME identification bilateral
92240Indocyanine-green (ICG) angiography with interpretation and reportSuperior for assessing deep choroidal involvement; useful when sarcoid or choroiditis is suspected
67028Intravitreal injection of a pharmacologic agentIntravitreal corticosteroid or antifungal therapy when systemic route insufficient

NCCI Bundling Considerations

NCCI PTP Edits — Verify Before Billing

  • 92250 (fundus photography) and 92235 (fluorescein angiography) billed same DOS are subject to NCCI PTP edit review. Confirm current edit status before billing both on the same date of service.
  • 67028 (intravitreal injection) performed same date as an E/M service: Modifier -25 (significant, separately identifiable E/M) must be appended to the E/M code when both are performed on the same date and the E/M is separately documentable beyond the procedure itself.
  • 92235 and 92240 billed together: review current NCCI edits; both angiography types may require separate medical necessity documentation if billed on the same encounter.

🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)

When H30.003 is an inpatient diagnosis and a procedure is performed, the following ICD-10-PCS sections and root operations are relevant. Full PCS codes require completion of all seven characters — consult the PCS tables for the applicable fiscal year.

PCS SectionBody SystemRoot OperationClinical Application
3 (Administration)E (Physiological Systems)0 (Introduction)Intravitreal injection of pharmacologic agent (corticosteroid, antiviral, antifungal) — Body Part C (Eye), Approach 3 (Percutaneous)
0 (Medical & Surgical)8 (Eye)9 (Drainage)Diagnostic vitreous tap/aspiration for culture or PCR — Body Part: Vitreous Right = 5, Left = 6; Approach 3 (Percutaneous), Qualifier X (Diagnostic)
0 (Medical & Surgical)8 (Eye)B (Excision)Vitreous biopsy if tissue sampling performed for diagnostic confirmation

💊 Coding Scenarios and Examples

Scenario 1 — Bilateral Reactivated Ocular Toxoplasmosis, Focal Unspecified Location (Outpatient)

Clinical Vignette: A 34-year-old female with known prior ocular toxoplasmosis presents with new floaters and blurred vision bilaterally. Fundus exam reveals a single active white fluffy lesion adjacent to an old chorioretinal scar in each eye (classic satellite lesion pattern), with overlying bilateral vitritis. The location of each active lesion is not specified as to anatomic zone in the note. Toxoplasma IgG positive, IgM negative. Treated with trimethoprim-sulfamethoxazole plus prednisone taper.

CPT Codes (Outpatient/Physician):

  • 92014 — Comprehensive ophthalmological exam, established patient
  • 92250 — Fundus photography, bilateral
  • 92134 — OCT posterior segment, bilateral

ICD-10-CM:

  • B58.01 — Toxoplasma chorioretinitis (etiology — sequences first)
  • H30.003 — Unspecified focal chorioretinal inflammation, bilateral (bilateral focal pattern adds specificity not captured by combination code alone)

B58.01 + H30.003 — When to Add the Ocular Code

B58.01 already incorporates the chorioretinal manifestation of toxoplasmosis. Adding H30.003 is most appropriate when the bilateral focal pattern adds meaningful clinical specificity relevant to the care episode — particularly in complex cases with bilateral involvement or when detailed laterality documentation is important.

Scenario 2 — Bilateral Focal Chorioretinitis, Etiology Unknown (Inpatient Admission)

Clinical Vignette: A 28-year-old male is admitted with bilateral decreased vision and new bilateral floaters over 5 days. Dilated fundus exam reveals a single discrete white-yellow lesion in each eye with surrounding retinal edema and overlying vitritis bilaterally. Location not specified in the ophthalmologist’s note as to posterior pole vs. peripheral. Extensive infectious workup (toxoplasma IgG/IgM, RPR/ FTA-ABS, QuantiFERON-TB Gold, HIV, CMV PCR) returns negative. Impression: bilateral idiopathic focal chorioretinitis. Admitted for IV corticosteroid therapy and monitoring.

Principal Diagnosis:

  • H30.003 — Unspecified focal chorioretinal inflammation, bilateral (no etiology identified — H30.003 is the principal)

Additional Diagnoses: All comorbidities meeting UHDDS criteria.

MS-DRG Assignment:

  • DRG 126 — Other Disorders of the Eye without CC/MCC (if no qualifying CCs/MCCs documented)
  • DRG 125 — with CC; DRG 124 — with MCC

CDI Opportunity — Query for Location Specificity

The admitting ophthalmologist documents “single discrete lesion, each eye” but does not specify posterior pole vs. peripheral. A CDI query asking for the anatomic location of the bilateral lesions could upgrade H30.003 to H30.023 (posterior pole, bilateral) or H30.033 (peripheral, bilateral), providing greater specificity without changing the clinical picture.

Scenario 3 — CMV Retinitis in HIV Patient, Bilateral Focal Chorioretinal Involvement (Inpatient)

Clinical Vignette: A 41-year-old male with HIV (CD4 count 18, AIDS stage) is admitted with bilateral decreased vision. Fundus exam reveals discrete areas of retinal whitening with hemorrhage at focal points bilaterally. CMV PCR positive. Impression: bilateral CMV chorioretinitis.

Principal Diagnosis:

  • B20 — Human immunodeficiency virus (HIV) disease (per ICD-10-CM Official Guidelines Section I.C.1.a.2 — B20 sequences as principal when HIV patient is admitted for an HIV-related condition; groups to MDC 25, NOT MDC 02)

Additional Diagnoses:

  • B25.8 — Other cytomegaloviral diseases (CMV retinitis)
  • H30.003 — Unspecified focal chorioretinal inflammation, bilateral (bilateral focal pattern specificity)

MDC Override — B20 as Principal Shifts to MDC 25

Assigning B20 as principal moves the entire encounter out of MDC 02 (Eye) into MDC 25 (HIV/AIDS). Do not sequence H30.003 as principal in an HIV-related chorioretinal admission — it will misgroup the case and trigger a DRG integrity issue.

Scenario 4 — Bilateral Sarcoid Chorioretinitis, Focal Pattern (Outpatient)

Clinical Vignette: A 47-year-old African American female with known pulmonary sarcoidosis presents with new bilateral floaters. Fundus exam: bilateral discrete focal choroidal granulomas at the posterior pole OU, with mild vitreous cells. Chest CT confirms active bilateral hilar lymphadenopathy — sarcoid diagnosis confirmed. Impression: bilateral sarcoid focal chorioretinitis, posterior pole.

CPT Codes:

  • 92014 — Comprehensive ophthalmological exam, established patient
  • 92240 — ICG angiography (superior for choroidal granuloma characterization)
  • 92134 — OCT posterior segment, bilateral

ICD-10-CM:

  • D86.83 — Sarcoidosis of eye (etiology — sequences first)
  • H30.023 — Focal chorioretinal inflammation, posterior pole, bilateral (location documented — upgrade from H30.003 to more specific posterior pole code)

Upgrade When Location Is Documented

This scenario illustrates the upgrade path: physician documented “posterior pole” — therefore H30.023 (bilateral, posterior pole) is correct, NOT H30.003 (bilateral, unspecified location). H30.003 would only apply here if the location had not been specified.

⚠️ Coding Pitfalls and Tips

Pitfall or Tip
❌Do not default to H30.003 if anatomic location is documented — juxtapapillary → H30.013, posterior pole → H30.023, peripheral → H30.033, macular/paramacular → H30.043
❌Do not confuse focal (H30.0x) with disseminated (H30.1x) — focal = single discrete lesion; disseminated = multifocal/widespread; the distinction must come from physician documentation, not coder inference
❌Do not code H30.003 simultaneously with H35.02- (Coats disease) — this is an Excludes 1 violation
❌Do not use H30.003 for an inactive/healed scar — old chorioretinal scars map to H31.0x (chorioretinal scars), not H30.0x (active inflammation)
❌Do not sequence H30.003 as principal in HIV-related admissions — B20 sequences first; case groups to MDC 25, not MDC 02
✅Query for anatomic location when documentation supports it — upgrading to H30.013/023/033/043 provides greater specificity and reflects true clinical detail
✅Query for focal vs. disseminated when only “chorioretinitis” is documented — the H30.0x vs. H30.1x distinction is a physician determination
✅Assign etiology codes when identified — B58.01 (toxoplasmosis), A51.43/A52.71 (syphilis), A18.53 (TB), D86.83 (sarcoid) — sequence etiology first
✅H30.003 is the bilateral code — use it when both eyes are documented with focal chorioretinal inflammation; do not use H30.001 + H30.002 when a bilateral code accurately reflects the documented condition
✅Sweep for HCC-bearing comorbidities at every H30.003 encounter — HIV, DM with complications, autoimmune conditions carry RAF weight that the ocular code does not

📚 Sources

  1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Tabular List — H30.003; H30.0 Focal chorioretinal inflammation subcategory structure; Excludes1/Excludes2 notations.

  2. Yanoff M, Duker JS. Ophthalmology, 5th ed. Elsevier; 2019. Posterior uveitis and chorioretinal inflammation chapters — focal vs. disseminated patterns, toxoplasmosis, sarcoidosis.

  3. CMS. 2025–2026 Medicare Advantage Risk Adjustment — CMS-HCC Model v28 ICD-10-CM Mappings. Baltimore, MD: Centers for Medicare & Medicaid Services.

  4. CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 02 logic tables.

  5. CMS. ICD-10-PCS Reference Manual FY2026. Section 0 (Medical & Surgical), Body System 8 (Eye); Section 3 (Administration).

  6. AMA. CPT Professional Edition 2026. Ophthalmology subsection (92002–92499) and Surgery guidelines.

  7. CMS. NCCI Policy Manual for Medicare Services, current version. Ophthalmology chapter and general correct coding principles.

Graph View

Recent Notes